Exicure, Inc. (XCUR) - Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. Exicure, Inc. is a smaller reporting company and non-accelerated filer. Historically an early-stage biotechnology firm, the Company is currently exploring strategic alternatives, including private acquisitions and capital raises, following the acquisition of GPCR Therapeutics USA Inc. in January 2025. The Company has no current revenue source and has issued a substantial doubt disclosure regarding its ability to continue as a going concern.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(1,828,000) | $3,010,000 (Income) |
| Operating Expenses | $1,640,000 | $(2,923,000) (Net Gain) |
| Cash and Equivalents (End of Period) | $2,604,000 | $10,420,000 |
| Net Cash Used in Operating Activities | $(1,142,000) | $(1,598,000) |
| Total Liabilities | $10,657,000 | $10,115,000 |
| Stockholders' Equity | $2,098,000 | $11,382,000 |
Note: Q1 2025 results included a $5.974 million gain on early lease termination which significantly impacted net income.
Material Changes vs. Prior Period
- Profitability Reversal: The Company reported a net loss of $1.8 million in Q1 2026, compared to net income of $3.0 million in Q1 2025. The prior year income was driven by a non-recurring $6.0 million gain from the early termination of a Chicago lease.
- Expense Reduction: Operating expenses decreased significantly due to restructuring. Research and Development (R&D) expenses fell 61% to $312,000, and General and Administrative (G&A) expenses fell 42% to $1.29 million, largely due to a reduction in full-time employees from 8 to 2.
- Liquidity Decline: Cash and cash equivalents decreased by $1.14 million during the quarter, leaving the Company with $2.6 million as of March 31, 2026.
- Contingent Liability: The fair value of contingent consideration (related to the GPCR acquisition) increased by $188,000, recorded as an expense.
Outlook, Risks, and Contingencies
- Going Concern: Management states that existing cash is insufficient to fund operations for the next 12 months. Additional financing is required to continue operations and explore strategic alternatives. Failure to raise capital could lead to bankruptcy or cessation of operations.
- Nasdaq Compliance: On May 28, 2026, the Company received a notice from Nasdaq regarding non-compliance with listing rules due to the delayed filing of this 10-Q. The Company intends to regain compliance upon filing.
- Legal Proceedings:
- Lease Dispute: The Company received a notice to pay approximately $0.7 million in unpaid rent for its Redwood City facility and was served with an unlawful detainer complaint. The Company vacated the facility in April 2026.
- Employee Litigation: A former employee lawsuit regarding unpaid wages and breach of contract remains pending. The Company has accrued $250,000, but potential liability could be significantly higher if Illinois Wage Payment and Collection Act (IWPCA) interest claims are upheld.
- Derivative Suits: A formal settlement agreement was executed in March 2026 regarding stockholder derivative lawsuits, pending final court approval in June 2026.
- Internal Controls: Management identified material weaknesses in internal controls over financial reporting, specifically regarding the review of non-routine activities and the design of accounting/IT processes.
- Milestone Payment: The Company intends to make a $1.0 million milestone payment to GPCR in Q2 2026 in the form of common stock shares.
Investor Verification Checklist
- Cash Runway: Verify the timeline for raising additional capital given the $2.6 million cash balance and $1.1 million quarterly burn rate.
- Lease Liability: Confirm the final resolution and potential financial impact of the $0.7 million Redwood City rent dispute.
- Legal Accruals: Monitor the outcome of the former employee lawsuit to determine if the $250,000 accrual is sufficient or if IWPCA interest will increase liability.
- Nasdaq Status: Track the Company's progress in regaining compliance with Nasdaq listing requirements to avoid delisting.
- Strategic Alternatives: Assess the likelihood and terms of any potential merger, acquisition, or partnership to generate revenue.